1-methyl-1,2,3,4-tetrahydro-beta-carboline-3-carboxylic acid has been researched along with Eosinophilia, Tropical in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kasahara, T; Miura, Y; Shioiri-Nakano, K; Suda, T; Tsunoda, J; Yamaguchi, Y | 1 |
3 other study(ies) available for 1-methyl-1,2,3,4-tetrahydro-beta-carboline-3-carboxylic acid and Eosinophilia, Tropical
| Article | Year |
|---|---|
Effect of synthesized constituents in the L-tryptophan product on the differentiation of eosinophils and the induction of IL-6: a possible cause of eosinophilia-myalgia syndrome.
Topics: Bone Marrow; Bone Marrow Cells; Carbolines; Cell Differentiation; Edema; Eosinophilia; Eosinophils; Hematopoietic Stem Cells; Humans; Interleukin-1; Interleukin-2; Interleukin-6; Muscular Diseases; Reference Values; Syndrome; Tryptophan | 1991 |
Analysis of L-tryptophan for the etiology of eosinophilia-myalgia syndrome.
Topics: Carbolines; Centers for Disease Control and Prevention, U.S.; Chromatography, High Pressure Liquid; Eosinophilia; Humans; Muscles; Pain; Syndrome; Tryptophan; United States; United States Food and Drug Administration | 1990 |
From the Centers for Disease Control. Analysis of L-tryptophan for the etiology of eosinophilia-myalgia syndrome.
Topics: Carbolines; Centers for Disease Control and Prevention, U.S.; Chromatography, High Pressure Liquid; Eosinophilia; Humans; Muscles; Pain; Syndrome; Tryptophan; United States; United States Food and Drug Administration | 1990 |